[ Back to EurekAlert! ]

Contact: William Davis
william_davis@med.unc.edu
919-966-5905
University of North Carolina Health Care

Novel Monoclonal Antibody Inhibits Tumor Growth in Breast Cancer and Angiosarcoma

Caption: Angiosarcoma cells treated with a monoclonal antibody targeting SFRP2 (right) show a significant reduction compared to an untreated control (left).

Credit: DeMore Lab, UNC School of Medicine

Usage Restrictions: None

Related news release: Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma


[ Back to EurekAlert! ]